The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes

Biomaterials

Volumn 30, Issue 30, 2009, Pages 6035-6040

  Yang, Darren ^a   Pornpattananangkul, Dissaya ^b,d   Nakatsuji, Teruaki ^c   Chan, Michael ^d   Carson, Dennis ^d   Huang, Chun Ming ^c,d   Zhang, Liangfang ^a,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Acne vulgaris; Antimicrobial; Drug delivery; Free fatty acid; Lauric acid; Liposome

Indexed keywords

ACNE VULGARIS; ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL; ANTIMICROBIAL STUDY; BACTERIAL MEMBRANES; BACTERICIDAL ACTIVITY; COCONUT OIL; DRUG DELIVERY VEHICLES; FREE FATTY ACID; HUMAN BREAST; LAURIC ACID; LOADING CONCENTRATION; NATURAL COMPOUNDS; PALMITIC ACID; PROPIONIBACTERIUM ACNES; WATER SOLUBILITIES;

BACTERIOLOGY; DRUG DELIVERY; LIPOSOMES; OLEIC ACID; PHOSPHOLIPIDS; VEGETABLE OILS;

ACIDS;

COCONUT OIL; FATTY ACID; LAURIC ACID; LIPOSOME; NATURAL PRODUCT; OLEIC ACID; PALMITIC ACID;

ACNE; ACNE VULGARIS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BREAST MILK; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SOLUBILITY;

ACNE VULGARIS; ANTI-INFECTIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FATTY ACIDS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; HYDROCARBONS; INFLAMMATION; LAURIC ACIDS; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; MILK, HUMAN; PLANT OILS; PROPIONIBACTERIUM ACNES;

BACTERIA (MICROORGANISMS); PROPIONIBACTERIUM ACNES;

EID: 69249216383     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.07.033     Document Type: Article

References (29)

1. Fried R.G., and Wechsler A. Psychological problems in the acne patient. Dermatol Ther 19 (2006) 237-240
2. Taglietti M., Hawkins C.N., and Rao J. Novel topical drug delivery systems and their potential use in acne vulgaris. Skin Therapy Lett 13 (2008) 6-8
3. Bojar R.A., and Holland K.T. Acne and Propionibacterium acnes. Clin Dermatol 22 (2004) 375-379
4. Bruggemann H., Henne A., Hoster F., Liesegang H., Wiezer A., Strittmatter A., et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305 (2004) 671-673
5. Burkhart C.G., Burkhart C.N., and Lehmann P.F. Acne: a review of immunologic and microbiologic factors. Postgrad Med J 75 (1999) 328-331
6. Webster G.F., and Leyden J.J. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 4 (1980) 261-269
7. Kim J. Review of the innate immune response in acne vulgaris: activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 211 (2005) 193-198
8. Nakatsuji T., Rasochova L., and Huang C.M. Vaccine therapy for P. acnes-associated diseases. Infect Disord Drug Targets 8 (2008) 160-165
9. Tanghetti E.A., and Popp K.F. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin 27 (2009) 17-24
10. Castro G.A., and Ferreira L.A. Novel vesicular and particulate drug delivery systems for topical treatment of acne. Expert Opin Drug Deliv 5 (2008) 665-679
11. Nakatsuji T., Kao M.C., Fang J.Y., Zouboulis C.C., Zhang L., Gallo R.L., et al. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol (2009) 10.1038/jid.2009.93
12. Schmid M.H., and Korting H.C. Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev 18 (1996) 335-342
13. Verma D.D., Verma S., Blume G., and Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258 (2003) 141-151
14. Honzak L., and Sentjurc M. Development of liposome encapsulated clindamycin for treatment of acne vulgaris. Pflugers Arch 440 (2000) R44-R45
15. Mezei M., and Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 34 (1982) 473-474
16. Lieb L.M., Ramachandran C., Egbaria K., and Weiner N. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the hamster ear model. J Invest Dermatol 99 (1992) 108-113
17. Bhalerao S.S., and Raje Harshal A. Preparation, optimization, characterization, and stability studies of salicylic acid liposomes. Drug Dev Ind Pharm 29 (2003) 451-467
18. Biju S.S., Ahuja A., and Khar R.K. Tea tree oil concentration in follicular casts after topical delivery: determination by high-performance thin layer chromatography using a perfused bovine udder model. J Pharm Sci 94 (2005) 240-245
19. Mayer L.D., Hope M.J., and Cullis P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 858 (1986) 161-168
20. Bodoprost J., and Rosemeyer H. Analysis of phenacylester derivatives of fatty acids from human skin surface sebum by reversed-phase HPLC: chromatographic mobility as a function of physico-chemical properties. Int J Mol Sci 8 (2007) 1111-1124
21. Ha T. Single-molecule fluorescence resonance energy transfer. Methods 25 (2001) 78-86
22. Bergsson G., Arnfinnsson J., Steingrimsson O., and Thormar H. Killing of gram-positive cocci by fatty acids and monoglycerides. APMIS 109 (2001) 670-678
23. Skrivanova E., Marounek M., Dlouha G., and Kanka J. Susceptibility of Clostridium perfringens to C-C fatty acids. Lett Appl Microbiol 41 (2005) 77-81
24. Nagayasu A., Uchiyama K., and Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev 40 (1999) 75-87
25. Haluska C.K., Riske K.A., Marchi-Artzner V., Lehn J.-M., Lipowsky R., and Dimova R. Time scales of membrane fusion revealed by direct imaging of vesicle fusion with high temporal resolution. Proc Natl Acad Sci U S A 103 (2006) 15841-15846
26. Zhang L., and Granick S. How to stabilize phospholipid liposomes (using nanoparticles). Nano Lett 6 (2006) 694-698
27. Carrion F.J., Delamaza A., and Parra J.L. The influence of ionic-strength and lipid bilayer charge on the stability of liposomes. J Colloid Interface Sci 164 (1994) 78-87
28. Bagalkot V., Zhang L., Levy-Nissenbaum E., Jon S., Kantoff P.W., Langer R., et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 7 (2007) 3065-3070
29. Beaulac C., Sachetelli S., and Lagace J. In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria. J Antimicrob Chemother 41 (1998) 35-41